Literature DB >> 7876642

Seroepidemiology of hepatitis A in the United States.

R S Koff1.   

Abstract

The seroepidemiology of hepatitis A depends on the biologic features of the agent. Hepatitis A virus (HAV) is shed in the stool, and infectivity titers are significantly higher for stool than for other body materials. As a consequence, the predominant mode of spread is through fecal-oral routes. Common-source vectors include contaminated foods, water, and bivalve mollusks. Risk factors include contact with a person with hepatitis A, attendance or employment at a day care center, recent international travel, exposure to infected food or water during an outbreak, homosexual activity, and injecting drug use. No known risk factors are identified in many cases. Almost 40% of individuals in the United States are seropositive for prior HAV infection, and rates increase with age, perhaps reflecting an aging cohort of persons infected in earlier times when the infection was more common. Not unexpectedly, this decrease in current infection rates has increased the number of susceptible persons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876642     DOI: 10.1093/infdis/171.supplement_1.s19

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Hepatitis A in day care centre.

Authors:  S D Chitambar; M S Chadha; L R Yeolekar; V A Arankalle
Journal:  Indian J Pediatr       Date:  1996 Nov-Dec       Impact factor: 1.967

2.  Molecular epidemiology of hepatitis A virus in metropolitan areas in Japan.

Authors:  Hideaki Takahashi; Hiroshi Yotsuyanagi; Kiyomi Yasuda; Tomohiko Koibuchi; Michihiro Suzuki; Tomohiro Kato; Tetsuya Nakamura; Aikichi Iwamoto; Kusuki Nishioka; Shiro Iino; Kazuhiko Koike; Fumio Itoh
Journal:  J Gastroenterol       Date:  2006-11-09       Impact factor: 7.527

3.  Epidemiological factors affecting hepatitis a seroprevalence in childhood in a developing country.

Authors:  Sevin Altınkaynak; Mukadder Ayşe Selimoğlu; Vildan Ertekin; Buket Kılıçaslan
Journal:  Eurasian J Med       Date:  2008-04

4.  Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey.

Authors:  M Sidal; E Unüvar; F Oğuz; C Cihan; D Onel; S Badur
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 5.  Active immunization in the United States: developments over the past decade.

Authors:  P H Dennehy
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  The prevalence of hepatitis A in children in British Columbia.

Authors:  Jan J Ochnio; David W Scheifele; Murray Fyfe; Mark Bigham; David Bowering; Paul Martiquet; Margaret Ho; Douglas N Talling
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

Review 7.  [Hepatitis as a travel disease].

Authors:  J Hadem; H Wedemeyer; M P Manns
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

8.  Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A.

Authors:  Arni S R Srinivasa Rao; Maggie H Chen; Ba' Z Pham; Andrea C Tricco; Vladimir Gilca; Bernard Duval; Murray D Krahn; Chris T Bauch
Journal:  BMC Infect Dis       Date:  2006-12-05       Impact factor: 3.090

Review 9.  Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review.

Authors:  Ba' Pham; Bernard Duval; Gaston De Serres; Vladimir Gilca; Andrea C Tricco; Jan Ochnio; David W Scheifele
Journal:  BMC Infect Dis       Date:  2005-07-07       Impact factor: 3.090

Review 10.  Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.

Authors:  D R Dufour; J A Lott; F S Nolte; D R Gretch; R S Koff; L B Seeff
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.